Aster DM Healthcare Share Price

    NSE
    633
    -17.05 (2.65%)
    ASTERDM • 04 Jul, 2025 | 03:29 PM
    BUY

    1Y Annualised Return

    88.37%

    3Y Annualised Return

    53.30%

    5Y Annualised Return

    40.20%

    The current prices are delayed, login or Open Demat Account for live prices.

    Aster DM Healthcare Stock Performance

    1W Return7.64
    1Y Return83.47
    Today's Low625.35
    Prev. Close650.05
    Mkt Cap (Cr.)32,804.83
    1M Return8.63
    3Y Return254.51
    52-Week High675
    Open643.90
    PE Ratio5.57
    6M Return21.44
    Today's High647.7
    52-Week Low315.5
    Face Value10

    Aster DM Healthcare Company background

    Founded in: 2008
    Managing director: Mandayapurath Azad Moopen
    Aster DM Healthcare Limited was erstwhile established as Aster DM Healthcare Private Limited, a private limited company on 18 January, 2008. On November 29, 2013. The Company was converted into a public limited company and the name of the Company was changed to Aster DM Healthcare Limited.Aster DM Healthcare Limited is one of the leading healthcare player in the GCC and India. Founded in 1987 by Dr. Azad Moopen, the Company has emerged as an integrated healthcare service organization that provides the complete circle of care to people through network of hospitals, clinics, labs and pharmacies, providing primary, secondary, tertiary to quaternary care to all segments of the population. Aster DM offer a diverse portfolio of specialised brands that serve patients in Primary, Secondary, Tertiary, and Quaternary Care, Healthcare Retailing, Diagnostic Laboratories, Digital Health, and Medical Education. With its patientcentric approach to medical care, the Company offer one of the largest and most widespread networks of Hospitals and Clinics, with the most premium healthcare facilities that aspire to make a difference. Its hospitals in India are located in Kochi, Kolhapur, Kozhikode, Kottakkal, Bengaluru, Vijayawada, Guntur, Ongole, Wayanad and Hyderabad and are generally operated under the Aster, MIMS, Ramesh or Prime brands. The company has one of the largest and most widespread network of clinics across the Middle East. Their extensive network in India spans 19 hospitals, 13 clinics, 215 pharmacies and 232 labs and patient experience centres across five Indian states with a total bed capacity of 4,867 as on March 2024. The Company commenced operations in 1987 as a single doctor clinic in Dubai established by the founder, Dr. Azad Moopen. Its first specialty medical centre was launched in Dubai in 1995. The Companys MIMS, or Malabar Institute of Medical Sciences, hospital in Kozhikode, Kerala, India, commenced operations in 2001. It started Qatar operations in 2003. In 2005, Al Rafa Hospital for Maternity and Surgery (now called Aster Day Surgery Centre LLC) commenced operations. In 2006, Medcare Hospital commenced operations.The Company was incorporated in January 18, 2008 as DM Healthcare Private Limited on January 18, 2008 at Kochi, Ernakulam, Kerala, in a reorganisation to facilitate the growth of its operations, subsequent to which operations in the GCC states and India were consolidated under the Company. In 2008, India Value Fund III A acquired 28.2% of the paid up Equity Share capital the company calculated at the time of investment. During the year under review, the company acquired majority stake in Prerana Hospital Limited (PHL), Kolhapur. In 2009, the companys Al Raffah Hospital located in Muscat, Oman, commenced operations. It extended its services to the Sultanate of Oman by establishing a medical centre in Sohar (ARMC) and a 30bed hospital in Ghubra, Muscat.In 2010, the company acquired 100% of the paid up equity share capital of Affinity Holdings Private Limited, Mauritius. During the year under review, the companys second Al Raffah Hospital in Oman commenced operations in Sohar. In 2011, the companys second Medcare Hospital, namely Medcare Orthopedics and Spine Hospital (Dubai) commenced operations.In 2012, Olympus Capital Asia Investments Limited acquired 25.47% stake in the company. During the year under review, the company conditionally acquired 40.80% of the paid up equity share capital of Sanad Al Rahma for Medical Care LLC.In 2013, the company acquired 60.35% of the paid up equity share capital of Indogulf Hospitals Private Limited (IHPL) and consequently Malabar Institute of Medical Sciences Limited (MIMS) became a subsidiary of the company.The company acquired hospital operational and management rights in Aster CMC, Bangalore pursuant to the hospital operation and management agreement dated May 12, 2014. In August 2014, the company launched Aster Medcity in Kochi, Kerala, a multispeciality hospital with a 670 bed capacity, to be positioned as a destination for medical value travel.In 2014, the company acquired 51% voting rights in Sainatha Hospitals, Andhra Pradesh, 54% stake in Aster Kuwait for Medicine and Medical Supplied Company WLL and 51% stake in Orange Pharmacies LLC, Jordan. In 2015, the companys first clinic in the Kingdom of Bahrain and Philippines commenced operations. In 2016, the company divested its stake in Medipoint Hospitals Private Limited, Pune. During the year under review, the company increased stake up to 70.68% in the paid up equity share capital of MIMS. During the year under review, the company increased stake up to 97% stake in Sanad Medical Care. During the year under review, the company acquired 51% stake in Dr Ramesh Hospital. During the year under review, the companys second clinic in Bahrain commenced operations. During the year under review, the companys Medcare Women and Child Hospital in Dubai became operational. During the year under review, the company launched its first multispecialty hospital in Sharjah.The company acquired hospital operational and management rights in DM Wayanad Institute of Medical Sciences, Wayanad pursuant to a medical services agreement and an operation and management agreement, both dated March 4, 2016.In 2017, the company entered into an operation and management agreement with the Rashtreeya Sikshana Samithi Trust to operate and manage a hospital in Bengaluru. During the year under review, the companys Medare Hospital Sharjah and Aster Hospital Doha commenced operations.On 9 April 2018, Aster DM Healthcare announced that it has entered into an agreement with Subramanya Constructions Development Company Limited (SCDC), a leading real estate developer, to construct a new hospital in Chennai. This 500 bedded, state of the art, multispecialty hospital is expected to commission in 2020. The hospital, which would be situated at a prime location in Chennai, will provide advanced healthcare services to the residents of Tamil Nadu and customers from other states in India as well as overseas.During the year 2018, Aster Ramesh Duhita LLP, Dr. Moopens Aster Hospital WLL, Harley Street Dental LLC and Aster DCC Pharmacy LLC have become subsidiaries of the Company.In Q4 FY19, Aster DM commenced Aster MIMS hospital, Kannur in the state of Kerala with bed capacity of 302 beds. It acquired Cedars Hospital in Dubia, UAE with bed capacity of 17 beds. It acquired Al Khair Hospital, in Ibri, Oman with bed capacity of 22 beds. Separate dedicated area for Physical Medicine and Rehabilitation was launched by Aster Medcity with capacity of 16 beds in Q3 FY19. It increased 150 beds with the acquisition of Ramesh Sanghamitra, Ongole under Aster Ramesh Hospitals. As on March 31, 2020 the Company has 9 direct subsidiaries, 67 stepdown subsidiaries and 4 associate companies. In FY 2020, Company unveiled teleMEDCARE, a unique telemedicine platform allowing patients to call doctors through video conferencing without the need for prior appointments, reaching quality healthcare to patients homes. In partnership with Sharjah Health Authority, it launched a fourmonth cervical cancer awareness drive in Sharjah and the Northern Emirates in October 2019 to ensure early diagnosis and consultations from leading gynaecologists and medical practitioners. It launched a Centre of Excellence for Management of Endometriosis,accredited by the British Society of Gynaecological Endoscopy, UK.In FY21, the Company had 76 subsidiaries and 7 associate companies. During FY 2021, Company was the first private healthcare player to introduce telemedicine in UAE and within 8 months enrolled 800 doctors consulting patients across the globe. It introduced home care services like doctors and nurses on call, vaccination and lab tests collection at home, delivery of prescription medicine at home which helped shift entire process of appointment booking to purchase of medicine to the homes of patients. Its homecare services were launched on a small scale, in tandem with the launch of teleMEDCARE in April 2020. Upon observing its performance, a dedicated team was hired, and the service officially launched in June 2020. Aster Hospital Al Qusais launched its dedicated Molecular Laboratory for COVID19 PCR Testing with stateoftheart facilities, highly qualified experts and very well trained nurses to provide accurate report less than 24 hours from testing. It introduced Cardio Thoracic Surgery and Neurosurgery Centre of Excellence for Vitreoretinal surgeries at Aster Hospital, Al Qusais.As on March 31, 2022, the Company has 73 subsidiaries and 8 associate companies. Hindustan Pharma Distributors Private Limited become subsidiary of the Company during the year 202122. Aster DM Healthcare introduced a new structure in India with 5 clusters namely the Kerala, Karnataka and Maharashtra, Andhra and Telangana, Pharmacy and the Aster Labs in FY22. It started a dedicated 77bed women and children wing at Aster MIMS hospital in Kerala which added to existing 244bed capacity at the facility. In Kolhapur, Maharashtra, it has operationalised 24 additional beds as part of Aster Aadhar Hospitals expansion. Recently in May 2022, it started operations at 140 bed Aster Mother Hospital in Areekode in Kerala. As of March 31, 2022, there were 2 Reference Labs, 12 Satellite Labs and 100 Patient Experience Centres (PEC). It acquired majority stake in Hindustan Pharma Distributors Private Limited and ventured into pharmacy business to optimize supply chain function of hospitals and franchised retail pharmacies. It signed an agreement with Alfaone Retail Pharmacies Private Limited (ARPPL) to license the Aster Pharmacy brand to run retail stores and online pharmacy operations. During FY22, ARPPL forayed into Telangana, Karnataka, and Kerala. As of March 31, 2022, there were 131 pharmacies, 82 in Karnataka, 27 in Kerala and 22 in Telangana serving 2.1 lakh customers in India. In June 2022, it announced the launch of the 550bed Aster Capital Hospital at Trivandrum, Kerala. In April 2022, Aster DM Healthcare launched 101bed multispecialty Aster Hospital in Sharjah to cater to the needs of the people in Northern Emirates of the UAE. It signed a Memorandum of Understanding with The Government of Tamil Nadu which proposes an investment of Rs. 500 crore in hospitals, pharmacies and laboratories in the State.The Company launched the 179 bed Aster Royal Hospital in Muscat, Oman and the 101 bed Aster Hospital in Sharjah in 202223. Aster India expanded its pharmacy network, reaching a milestone of 106 stores in Karnataka, 85 stores in Kerala, 61 stores in Telangana, and 5 stores in Andhra Pradesh by the end of FY23. Aster Labs increased its foot prints to 189 Patient Experience Centres (PEC), 15 Satellite Labs, and 1 Reference Lab.Adiran IB Healthcare Private Limited, Komali Fertility Centre Ongole LLP, Cantown Infra Developers LLP and Zest Wellness Pharmacy LLC, became subsidiaries of the Company and Skin III Ltd became associate of the Company during the year 202223.In 2024, the Company launched its Whitefield Hospital in Bangalore. It completed the segregation of the Gulf Corporation Council (GCC) business through the sale by Affinity Holdings Pvt Ltd, on April 03, 2024.

    As of 04 Jul, 2025, Aster DM Healthcare share price is ₹633.2. The stock opened at ₹643.9 and had closed at ₹650 the previous day. During today’s trading session, Aster DM Healthcare share price moved between ₹625.35 and ₹647.70, with an average price for the day of ₹636.53. Over the last 52 weeks, the stock has recorded a low of ₹315.50 and a high of ₹675.00. In terms of performance, Aster DM Healthcare share price has increased by 21.4% over the past six months and has increased by 88.37% over the last year.

    Read More
    Aster DM Healthcare SIP Return Calculator

    Over the past

    1 year
    3 years
    5 years

    Total Investment of ₹65,00,000

    Would have become ₹1,04,52,274 (+60.80%)

    Daily SIP of 25,000 would have become 1,04,52,274 in 1 year with a gain of 39,52,274 (+60.80%)

    View details of Market Depth

    Aster DM Healthcare Fundamental

    Market Cap (in crs)

    32,804.83

    Face Value

    10

    Turnover (in lacs)

    28,109.77

    Key Metrics

    Qtr Change %
    New 52W High in past week
    31.2
    Dividend yield 1yr %
    Below industry Median
    0.9

    Aster DM Healthcare Key Financials

    View more

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    Aster DM Healthcare Quarterly Revenue
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    1000.34 Cr
    1049.81 Cr
    1086.44 Cr
    1001.87 Cr
    973.59 Cr
    Aster DM Healthcare Yearly Revenue
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    4286.69 Cr
    3723.75 Cr
    12011.13 Cr
    10303.94 Cr
    8658.4 Cr
    8776.37 Cr
    Aster DM Healthcare Quarterly Net Profit/Loss
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    95.55 Cr
    67.98 Cr
    108.36 Cr
    83.71 Cr
    44.61 Cr
    Aster DM Healthcare Yearly Net Profit/Loss
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    5426.8 Cr
    216.02 Cr
    474.27 Cr
    600.51 Cr
    174.31 Cr
    314.85 Cr

    Aster DM Healthcare Result Highlights

    • Aster DM Healthcare Ltd reported a 9.7% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a - of -.

    • Its expenses for the quarter were down by 5.4% QoQ and - - YoY.

    • The net profit decreased 103.4% QoQ and - - YoY.

    • The earnings per share (EPS) of Aster DM Healthcare Ltd declined at 0.5 during Q4FY25.

      Read more

    Data Source: BSE, Company announcements

    The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

    Top Mutual Fund Invested in Aster DM Healthcare

    Promoter
    41.9%
    Foreign Institutions
    21.7%
    Mutual Funds
    23.3%
    Domestic Institutions
    24.5%
    Public
    11.6%
    Promoter
    41.9%
    Foreign Institutions
    22.6%
    Mutual Funds
    22.2%
    Domestic Institutions
    22.9%
    Public
    12.3%
    Promoter
    41.9%
    Foreign Institutions
    23.9%
    Mutual Funds
    20.2%
    Domestic Institutions
    20.9%
    Public
    13%
    Promoter
    41.9%
    Foreign Institutions
    27.1%
    Mutual Funds
    15.7%
    Domestic Institutions
    16.3%
    Public
    14.4%
    Promoter
    41.9%
    Foreign Institutions
    33.5%
    Mutual Funds
    13.6%
    Domestic Institutions
    13.7%
    Public
    10.6%
    Promoter
    41.9%
    Foreign Institutions
    41%
    Mutual Funds
    7.1%
    Domestic Institutions
    7.2%
    Public
    9.6%

    Aster DM Healthcare Technical Analysis

    Moving Averages Analysis
    633
    Current Price
    Bullish Moving Averages
    16
    Bearish Moving Averages
    0
    5Day EMA
    618.00
    10Day EMA
    603.90
    12Day EMA
    600.20
    20Day EMA
    589.60
    26Day EMA
    583.30
    50Day EMA
    561.20
    100Day EMA
    529.00
    200Day EMA
    490.80
    5Day SMA
    612.40
    10Day SMA
    598.60
    20Day SMA
    584.20
    30Day SMA
    575.80
    50Day SMA
    562.90
    100Day SMA
    505.30
    150Day SMA
    502.10
    200Day SMA
    483.50
    Delivery & Volume

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    1310441 Rs
    4631483 Rs
    Week Rs
    1137516 Rs
    5999260 Rs
    Month Rs
    700498 Rs
    2219084 Rs
    635.40
    Pivot
    Resistance
    First Resistance
    645.45
    Second Resistance
    657.75
    Third Resistance
    667.80
    Support
    First Support
    623.10
    Second support
    613.05
    Third Support
    600.75
    Relative Strength Index
    66.33
    Money Flow Index
    74.28
    MACD
    16.94
    MACD Signal
    12.05
    Average True Range
    22.56
    Average Directional Index
    29.89
    Rate of Change (21)
    7.88
    Rate of Change (125)
    21.27
    Name
    Holding Percent
    Hdfc Small Cap Fund
    6.88
    Kotak Small Cap Fund
    3.4
    Franklin India Smaller Companies Fund
    2.92
    Sbi Contra Fund
    2.37
    Quant Mutual Fund - Quant Small Cap Fund
    2.27
    Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund
    1.99
    Smallcap World Fund, Inc
    3.27
    Rimco (Mauritius) Limited
    8.58

    Aster DM Healthcare Latest News

    04 JUL 2025 | Friday

    Aster DM Healthcare Ltd - 540975 - Reply On Clarification Sought On Spurt In Volume

    04 JUL 2025 | Friday

    Aster DM Healthcare Ltd - 540975 - Clarification sought from Aster DM Healthcare Ltd

    03 JUL 2025 | Thursday

    Max, Aster DM, Apollo rally up to 7%; what's driving hospital stocks today?

    View More

    Aster DM Healthcare Share Price FAQs

    Aster DM Healthcare share price is ₹633 in NSE and ₹634.95 in BSE as on 4/7/2025.

    Aster DM Healthcare share price in the past 1-year return was 83.46. The Aster DM Healthcare share hit a 1-year low of Rs. 315.5 and a 1-year high of Rs. 675.

    The market cap of Aster DM Healthcare is Rs. 32804.83 Cr. as of 4/7/2025.

    The PE ratios of Aster DM Healthcare is 5.57 as of 4/7/2025.

    The PB ratios of Aster DM Healthcare is 7.93 as of 4/7/2025

    The Mutual Fund Shareholding in Aster DM Healthcare was 23.29% at the end of 4/7/2025.

    You can easily buy Aster DM Healthcare shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Aster DM Healthcare share price is ₹675 and ₹315.5 as of 4/7/2025.

    Please be aware that Aster DM Healthcare stock prices are subject to continuous fluctuations due to various factors.

    Popular Stocks
    65.53
    +0.26 (+0.40%)
    139.24
    -0.46 (-0.33%)
    689.05
    -1.35 (-0.20%)
    2,599.10
    -12.10 (-0.46%)
    166.67
    -0.85 (-0.51%)
    391.40
    +0.75 (+0.19%)
    163.01
    -2.90 (-1.75%)
    261.40
    +0.55 (+0.21%)
    427.55
    +1.30 (+0.30%)
    401.00
    +1.10 (+0.28%)
    Top Gainers
    925.30
    +15.15 (+1.66%)
    1,640.70
    +22.00 (+1.36%)
    1,307.40
    +16.10 (+1.25%)
    1,442.80
    +16.90 (+1.19%)
    270.05
    +3.00 (+1.12%)
    Top Losers
    5,456.00
    -735.00 (-11.87%)
    163.01
    -2.90 (-1.75%)
    5,629.00
    -87.00 (-1.52%)
    1,655.20
    -16.70 (-1.00%)
    12,646.00
    -106.00 (-0.83%)
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -